Dr. Charis Meng is a rheumatologist in the Inflammatory Arthritis Center, with expertise in rheumatoid arthritis, polymyalgia rheumatica, psoriatic arthritis, spondyloarthropathy, osteoarthritis and gout. Dr. Meng’s research interests include rheumatoid arthritis therapies and pain management.
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Assistant Attending Physician, Hospital for Special Surgery
Assistant Professor of Clinical Medicine, Weill Cornell Medical College
American Board of Internal Medicine, Diplomate
Arthritis Foundation Fellowship Award
Magna Cum Laude, Brown University
Sigma Xi, Brown University
MD, Brown University School of Medicine, Providence, Rhode Island
Mount Sinai Medical Center, Internal Medicine
Hospital for Special Surgery, Rheumatology
For all publications, please see the PubMed listing.
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of May 31, 2023, Dr. Meng reported no relationships with the healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.